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1. Introduction 
Ricin is one of the most toxic and easily produced plant toxins. It is derived from the castor 
plant, Ricinus communis (Fig. 1), a shrub native to Africa but currently is being cultivated in 
many areas of the world for its co mmercial products, primarily castor oil. The seeds of R. 
communis, commonly called beans (although not a true bean) (Fig. 2), are oblong, brown, 
and have a thick mottled shell sometimes used to make decorative necklaces and bracelets. 
Castor seeds contain 40 to 60% vegetable oil that is rich in triglycerides, mainly ricinolein 
(McKeon et al., 1999). Castor oil is used in a number of products. For many years, purified 
castor oil has been ingested as a human nutritional supplement, emetic, or purgative 
worldwide (Scarpa and Guerci, 1982; Caupin, 1997; Olsnes, 2004). In addition to castor oil 
production, castor plants are also being grown for aesthetic (ornamental garden bush) and 
ecological values. It is used extensively as a decorative plant in parks and other public areas. 
Ecologically, despite the ricin being poisonous to humans and many animals, R. communis is 
the host plant of insects including moths and butterflies, and is also used as a food plant by 
some Lepidopteran larvae and birds.  
 
Fig. 1. Castor plant, Ricinus communis, a large shrub having large palmate leaves and spiny 
capsules containing seeds that are the source of castor oil and ricin (Adapted from 
http://dtirp.dtra.mil/images/RicinusCommunis.jpg)  
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Castor seeds contain large amounts of ricin, which is also present in lower concentrations 
throughout the plant. Ricin content significantly varies among cultivars/accessions and may 
range from 0.1 to 4% of the weight of the seed (Auld et al., 2003; Baldoni et al., 2011; 
Pinkerton et al., 1999). Ricin is one of the most potent poisons in the plant kingdom (Lee & 
Wang, 2005). Because of the wide availability of its source plants, ease of production, 
stability, and lethal potency, ricin toxin is considered to be a bioterrorism threat. Ricin is the 
most common biological agent used in biocrimes, and has also been reported as one of the 
most prevalent agents involved in WMD (weapons of mass destructions) investigations 
(FBI, n.d.). Recent attempted uses of ricin by various extremists and radical groups have 
heightened concerns regarding ricin’s potential for urban terrorism.  
 
Fig. 2. Castor seeds (Adapted from 
http://www.ars.usda.gov/is/AR/archive/jan01/plant0101.htm) 
2. History, biological warfare and terrorism 
The castor plant belongs to the genus Ricinus of the Euphorbiaceae or spurge family 
(Atsmon, 1985). R. communis is indigenous to the southeastern Mediterranean region, 
eastern Africa, and India, but is now widespread throughout temperate and subtropical 
regions (McKeon et al., 2000; Phillips & Rix, 1999). The gourd mentioned in the Book of 
Jonah (Jon 4:6-9; Old Testament), bears the Hebrew name kikayon, and is presumed to be 
the kiki of the Egyptians, the castor-oil plant (Easton’s Bible Dictionary, n.d.). It is commonly 
known as “Palm of Christ” or Palma Christi, that derives from castor oil's ability to heal 
wounds and cure ailments. Castor seeds have been found in Egyptian tombs dating back to 
4000 BC, and were used in folk medicines against a wide variety of diseases. The plant has 
been cultivated for its commercial products, primarily castor oil, for at least 4000 years 
(Olsnes, 2004). Castor oil was used in rituals of sacrifice to please the gods in early 
civilizations. In Ancient Egypt and in Europe, it has been used for lighting, body ointments, 
improving hair growth and texture, and medicinal purposes, where it was regarded as a 
folk medicine. In India, castor oil has been documented since 2000 BC and was mainly used 
in lamps and in local medicine as a laxative, purgative, cathartic and other ethnomedical 
systems. In China, castor seed and its oil have been prescribed for centuries in local 
medicine for internal use. In Italy, castor oil was used as an instrument of coercion by the 
Squadristi, the Fascists armed squads of dictator Benito Mussolini; this idea originated from 
Gabriele D‘ Annunzio, a controversial nationalist, poet and war veteran (MacDonald, 1999). 
Political dissidents and regime opponents were forced to ingest the oil in large amounts, 
triggering severe diarrhea and dehydration that oftentimes led to death (New World 
Encyclopedia, n.d.).  
www.intechopen.com
 
Ricin Perspective in Bioterrorism 
 
135 
In recent centuries, however, natural castor oil was at first identified as a laxative and as a 
lubricant for the wheels of wagons and carts, as well as aircrafts during World War I (WWI). 
Today, castor oil (extracted minus the ricin) has a wide variety of commercial applications 
(International Castor Oil Association, ICOA, 1992). It is used for medicinal purposes both 
internally, as a strong and effective purgative or cathartic, and externally to treat corns, 
among other purposes (Sims & Frey, 2005). Castor oil and its derivatives also have 
numerous industrial merits, being used in a wide variety of products, such as the basic 
ingredient in racing motor oil for high-performance engines, a fuel additive for two-cycle 
engines, a primary raw material in the production of nylons and other resins and fibers, and 
a component in paint and varnish, insulation, fabric coatings, soap, ink, plastics, hydraulic 
fluids, lubricants, guns, insecticidal oils, cosmetics, and antifungal compounds (Brugsch, 
1960; Caupin, 1997; McKeon et al., 1999; Sims & Frey, 2005). Because of its economic benefits 
and myriads of uses, castor seeds are currently being produced in more than 30 countries in 
the world. In 2008, world’s production of castor oil totaled to 1,605,362 metric tons (MT) 
(Food and Agricultural Organization of the United Nations Statistical Database, FAOSTAT, 
2011); the leading producers include India (1,171,000 MT), China (190,000 MT), and Brazil 
(122,140 MT). After oil extraction and inactivation of ricin, the defatted waste “mash“ (also 
called castor bean meal) is used as animal feed while the seed husks are used as high 
nitrogen fertilizer (Kole, 2011).  
Ricin toxin was discovered in 1888 by Hermann Stillmark, a student at the Dorpat 
University in Estonia (Stillmark, 1888, as cited in Franz and Jaax, 1997). During Stillmark‘s 
extensive research, he also observed that ricin caused agglutination of erythrocytes and 
precipitation of serum proteins (Olsnes, 2004). Olsnes and Phil (1972) demonstrated that 
ricin inhibited protein synthesis, and suggested that the effects resulted from restricted 
elongation of nascent polypeptide chain. Subsequent studies revealed that the molecular 
target of the toxin was the 60S ribosomal subunit (Olsnes and Phil, 1982). 
In the last decade, immunotoxins using the ricin A-chain chemically-linked to monoclonal 
antibodies have been used as an alternative in therapies against cancer, AIDS and other 
illnesses (Engert et al., 1997; Schnell et al., 2003; Youn et al., 2005). Ricin-based 
immunotoxins, some of which contained deglycosylated ricin A chain conjugated to either 
the anti-CD22 antibody RFB4 (Amlot et al., 1993; Sausville et al., 1995), or its Fab fragment 
(Vitetta et al., 1991) have also been shown to provide enhanced therapeutic efficacy and 
resulted in improved antitumor activity (Li et al., 2005; Kreitman et al., 2005; Vitetta, 2006). 
However, the U.S. Food and Drug Administration (FDA) has placed a hold on the clinical 
testing of RTA-based immunotoxins because they caused vascular leak syndrome (VLS) in 
humans.  
2.1 Biological warfare and terrorism 
2.1.1 History of ricin as a biological weapon 
During WWI, ricin was investigated as a potential offensive biological weapon. Two 
methods of weaponizing the toxin were explored, i.e., bullets and shrapnel coated with 
ricin, or a 'dust cloud' of toxin inhaled into the lungs (Smart, 1997). Nonetheless, the thermal 
instability of ricin constrained its initial use in exploding shells, and ethical and treaty issues 
limited its use as a poison or blinding agents (Hunt et al., 1918, as cited in Millard & 
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LeClaire, 2007). WWI ended before the toxin could be weaponized and tested. During 
WWII, ricin was produced in hundreds of kilograms and armed into W bombs (ricin-
containing bombs), but apparently was never used in battle (Franz & Jaax, 1997). Although 
its toxicity made it marginally better over existing agents, ricin was surpassed by the even 
more potent biological agents of the time. Interest in ricin continued for a short period after 
WWII, but soon subsided when the U.S. Army Chemical Corps began a program to 
weaponize sarin. During the Cold War, the Soviet Union also studied ricin as a possible 
biological weapons agent. Ken Alibek, a former top official involved in Russia’s biological 
weapons program who defected to the U.S. in 1991, claimed that Russia developed ricin 
toxin as a weapon, and that the ricin toxin used against the Bulgarian dissident Georgi 
Markov, as well Vladimir Kostov (another Bulgarian exile in Paris), was concocted in 
Russian laboratories (Maman & Yehezkelli, 2005). During 1989, approximately 10 L of 
concentrated ricin solution was reportedly manufactured at Salman Park just south of 
Baghdad, some of which were used in animal testing and as payload in artillery shells 
(Zilinskas, 1997). More recently, ricin has been used by terrorist organizations (CDC, 2008). 
In 2002, a report emerged that Ansar al-Islam, a Sunni Islamic group allegedly linked to 
Osama Bin Laden's al-Qaeda organization, had been testing biological weapons including 
ricin at a small facility in northern Iraq (BBC News, 20 August 2002). A news item 
documented evidence of the manufacture of ricin and botulinum toxin in Iraq (Mendenhall, 
2003). Syria was also believed to have produced unknown quantities of the toxin. Iran 
allegedly procured 120 tons of castor beans in 1992, presumably for ricin production 
(Croddy & Wirtz, 2005). Ricin was also found in Afghanistan after the collapse of the 
Taliban Government in 2001 (GlobalSecurity.org, n.d.; Barceloux, 2008).  
Ricin is currently monitored as a Schedule 1 toxic chemical under the Convention on the 
Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and 
on Their Destruction (CWC). Also, the intentional use of ricin or related toxins as weapons is 
prohibited under the 1972 Convention on the Prohibition of the Development, Production 
and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their Destruction 
(BTWC) (Millard & Le Claire, 2007; Poli, 2007). The possession or transfer of ricin, abrin, or 
genes encoding functional forms of these toxins is also regulated in the U.S. by the Centers 
for Disease Control and Prevention (CDC) Select Agents and Toxins Program.  
Although ricin’s potential use as a military weapon was investigated, its utility over 
conventional weaponry remains disputed. Despite its toxicity, ricin is less potent than 
other agents such as botulinum neurotoxin or anthrax. Kortepeter & Parker (1999) 
estimated that eight metric tons of ricin would have to be aerosolized over a 100 km2 area 
to achieve about 50% casualty, whereas only kilogram quantities of anthrax spores would 
cause the same effect. Furthermore, dispersal of ricin on a wide scale is logistically 
impractical. Thus, while ricin is easy to produce, it is not as likely to cause as many 
casualties as other agents (Schep et al., 2009). However, it has been the agent of choice in 
numerous biocrimes (see below). 
2.1.2 Ricin as a terrorist weapon 
Ricin has been classified by the CDC as a Category B agent. Category B agents are 
moderately easy to disseminate, can cause morbidity and low mortality, and include Coxiella 
burnetii, Brucella spp, Burkholderia mallei, B. pseudomallei, alphaviruses (VEE, EEE, WEE), 
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Rickettsia prowazekii, toxins (e.g., ricin, Staphylococcal enterotoxin B, epsilon toxin of 
Clostridium perfringens), Chlamydia psittaci, food safety threats (e.g., Salmonella spp., 
Escherichia coli O157:H7, Shigella), and water safety threats (e.g. Vibrio cholerae, 
Cryptosporidium parvum) (Rotz et al., 2002). Though ricin is not considered an effective 
weapon of mass destruction, its potential as a weapon of terror cannot be discounted. 
Further, ricin’s notoriety is likely driven by the ready availability of castor beans, press 
coverage, and popularization on the internet. In the U.S. for example, the use of ricin as a 
biological agent in bioterrorism and homicides is of particular concern especially after the 
events of September 11, 2001. Worldwide, numerous cases involving the possession, 
experimentation, or planned misuse of ricin by bioterrorists and extremist groups have been 
investigated or prosecuted by law enforcement agencies (Franz and Jaax, 1997; James Martin 
Center for Nonproliferation Studies (CNS), 2004; Research International, Inc. (RII), 2011). 
The following incidents have reportedly involved the use and/or possession of ricin.  
 On September 7, 1978 while waiting at a bus stop in London, a Bulgarian dissident, 
Georgi Markov, felt a jab in the back of his right thigh and saw a man picking up an 
umbrella (Crompton & Gall, 1980). Markov, a 49-year-old novelist and playwriter had 
published and broadcasted anticommunist views. An assassin reportedly injected a 
small pellet of ricin (believed to have been supplied by the KGB), into Markov’s right 
thigh using a weapon in the shape of an umbrella (Maman & Yehezkelli, 2005). He 
subsequently developed severe gastroenteritis, high fever, and died 3 days later 
(discussed in detail later in this chapter). At autopsy, a small 1.53-mm metallic sphere 
that had 2 tiny holes and could hold a volume of 0.28 mm3, was found at the wound 
site. No specific isolation of any poison was possible. Because of the small volume and 
rapid demise of the patient, ricin was believed to be the only capable inciting agent. The 
coroner recreated the scenario by injecting a pig with a somewhat greater dose than 
Markov had received (Crompton & Gall, 1980). With an illness similar to Markov’s, the 
animal died 26 hours later. Thereafter the coroner was satisfied that Markov had been 
unlawfully killed by a tiny pellet containing 0.2 to 0.5 mg dose of ricin (Musshoff & 
Madea, 2009). The KGB denied any involvement although high-profile defectors Oleg 
Kalugin and Oleg Gordievsky have since confirmed the KGB's involvement (Pearce, 
2011). 
 In 1981, exposed CIA double agent Boris Korczak was reportedly shot with a ricin-laced 
pellet (Carus, 2002). He survived this assassination attempt which was thought to be the 
work of the KGB.  
 In 1982, William A. Chanslor, a Texas attorney was sentenced to jail for 3 years and 
fined $5,000 for plotting to kill his 39-year-old wife with ricin. He claimed that he 
wanted the ricin to assist his wife, paralyzed from the waist down due to a stroke, in 
committing suicide (Time Magazine, 16 August 1982).  
 In 1983, two brothers were arrested by the Federal Bureau of Investigation (FBI) for 
producing an ounce of pure ricin (RII, 2011).  
 In 1983 and 1985, Montgomery Todd Meeks, a high school senior was tried and 
convicted of attempted murder and solicitation to murder in connection with a plot to 
kill his father using ricin (Trager, 1985, as cited in Carus (2002). He claimed that the act 
was motivated by his father's abuse (RII, 2011).  
 In 1991, four members of the Minnesota Patriots Council, a radical tax-protesting militia 
organization, acquired castor beans and planned to use ricin to assassinate local deputy 
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sheriffs, U.S. Marshals, and IRS agents. Despite having no specific expertise in 
biological warfare, they extracted about 0.7 g of 5% ricin, which was enough to kill 
about 100 people. Two members were convicted in 1994, and the other two in 1995 
under the Biological Weapons Anti-Terrorism Act (BWATA) law (RII, 2011). 
 On April 21, 1992, the Washington Post published an article regarding the unsuccessful 
attempt to poison the famous Soviet dissident Alexander Solzhenitsyn with the same 
lethal chemical (thought to be ricin) used to kill Bulgarian dissident Georgi Markov in 
London in 1978 (Remnick, 21 April 1992). 
 In December 1995, Thomas Lewis Lavy, an electrician from Valdez, Alaska was arrested 
in Onia, Arkansas for possession of ricin (Kifner, 2005). In April 1993, he was caught 
while trying to smuggle 130 g of ricin and other materials from Alaska into Canada, and 
was then charged under BWATA with possession of a biological toxin with intent to 
kill. Lavy killed himself in his prison cell several days after his arrest (RII, 2011). 
 In 1995, a federal case was brought against Dr. Ray W. Mettetal, Jr., a neurologist at 
Rockingham Memorial Hospital in Harrisonburg, Virginia, after ricin was discovered in 
his possession and also of providing false information (Carus, 2002).  
 In 1995, Deborah Green, a non-practicing oncologist from Prairie Village, Kansas, 
attempted to murder her husband, Michael Farrar, a cardiologist, with ricin (Musick, 
25 May 2000; Carus 2002). Green had purchased the castor beans through a special 
order from a garden center in Kansas City, Missouri, and placed them in Farrar’s 
food. It is unclear if she extracted the ricin or merely added the beans to the food. 
Later, Farrar had to undergo multiple heart and brain surgeries related to the 
poisoning (CNS, 2004). 
 In 1997, a man was indicted under the provisions of BWATA for possessing ricin and 
nicotine sulfate. He pled guilty to manufacturing ricin and was sentenced to more than 
12 years in prison (Cordesman, 2002). 
 On August 25, 1998, Dwayne Lee Kuehl was arrested in Escanaba, Michigan, for 
producing ricin with intent to use it against an Escanaba city housing inspector (RII 
2011).  
 In November 1999, FBI agents apprehended James Kenneth Gluck in Tampa, Florida, 
for threatening to kill court officials in Jefferson County, Colorado with ricin (The New 
York Times, 08 November 1999). 
 In August 2001, the FSB (Russian Federal Security Service) told the Itar-Tass news 
service it had intercepted a recorded conversation between two Chechen field 
commanders (Brigadier General Rizvan Chitigov and field commander Hizir 
Alhazurov) about instructions on the homemade production of poisons against Russian 
troops (RII, 2011). Russian authorities reportedly raided Chitigov's home and seized 
materials, including instructions on how to produce ricin from castor beans, a small 
chemical laboratory, three homemade explosives, two land mines, and 30 grenades 
(Gad, 2007).  
 In June 2002, Ken Olson, an Agilent software engineer, was convicted of ricin 
possession (Tizon, 2004). He was given a 13-year, 9-month sentence in April 2004.  
 In August 2002, the Sunni miltant group Ansar al-Islam was reported to be involved in 
testing biological agents including ricin on barnyard animals and perhaps even an 
unwitting human subject (BBC News, 20 August 2002).  
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 In December 2002, six terrorist suspects were arrested in Manchester, England. Their 
apartment was serving as a “ricin laboratory.” Among them was a 27-year-old chemist 
who was producing the toxin (CDC, 2003a). 
 In January 2003, authorities discovered traces of ricin in the apartment of six 
Algerians in Wood Green, northern London (Hopkins & Branigan, 08 January 2003). 
They also discovered castor beans and equipment for crushing the beans. Those 
arrested are believed to be part of a terrorist cell known as the “Chechen network“ 
which may have ties to the Algerian group behind the millennium bomb plots in the 
U.S. All but one of the suspects was acquitted of charges in April, 2005 (Research 
International, 2011).  
 In October 2003, an envelope with a threatening note and a sealed container that had 
ricin in it was discovered at a mail processing and distribution facility in Greenville, 
South Carolina. The note threatened to poison water supplies if demands were not met 
(CDC, 2003b). 
 In February 2004, traces of ricin were discovered on an automatic mail sorter in the 
mailroom of the Dirksen Senate Office building in Washington, D.C which handled 
mail addressed to Senate Majority Leader Bill Frist (CNN.com, 04 February 2004). 
 In January 2005, the FBI arrested an Ocala, Florida man after agents found ricin and 
other products in the home he lives in with his mother (CNN.com, 14 January 2005). 
 On October 3, 2006, a survivalist from Phoenix, Arizona was sentenced to 7 years in 
prison for attempting to manufacture ricin (Martens, 2006). 
 In 2007, traces of ricin had been found at Limerick Prison (Lally, 2007). The ricin was 
smuggled into Ireland from the U.S. in a contact lens case, to be used in an assassination 
plot. An arrest was made before the ricin could be used (RII, 2011).  
 In November 2008, Roger Von Bergendorff was fined and sentenced to 3.5 years in 
prison for having ricin and unregistered firearm silencers. In February 2008, 
Bergendorff was living in a motel room in Las Vegas, Nevada when he was taken to a 
hospital in critical condition. Authorities recovered castor beans, a weapons cache, a 
copy of "The Anarchist Cookbook" with a page about ricin marked, and 4 crude grams 
of ricin in his room. Investigators also found respirators, gloves and chemicals that 
could be used in the production of ricin in one of Bergendorff's storage units in Utah 
(Powers, 18 November 2008). 
 In June 2009, a father and son, Ian and Nicky Davison were arrested after the 
discovery of ricin at a house in County Durham (BBC News, 06 June 2009). Ian 
Davidson was sentenced to 10 years in May 2010 for preparing acts of terrorism, three 
counts of possessing material useful to commit acts of terrorism and possessing a 
prohibited weapon; his son was given 2 years youth detention for possessing material 
useful to commit acts of terrorism (Wainwright, 2010).In January 2011, The FBI has 
arrested the owner of a Coventry Township, Ohio home for unlawful possession of 
ricin (Sharma, 29 January 2011).  
 In June 2011, Michael Crooker, a former Agawam man, was sentenced to 15 years in 
federal prison for illegally possessing ricin and threatening a prosecutor (Associated 
Press, AP, 22 June 2011). In another report during the same period, a British citizen, 
Asim Kauser, was brought to court on charges including possessing instructions for 
producing ricin (Global Security Network, GSN, 17 June 2011).  
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The above events clearly demonstrate that ricin is readily available or accessible, relatively 
easy to produce, and seemingly, a biological weapon of choice by extremist groups and 
individuals. Hence, it should be seriously considered as a potential bioterrorism threat 
agent. 
3. Description of the agent 
3.1 Overview of ribosome-inactivating proteins 
Ricin belongs to a diverse family of ribosome-inactivating proteins (RIPs) that include 
numerous other toxins from a wide variety of plants, as well as potent bacterial Shiga and 
Shiga-like toxins (Endo et al., 1988). RIPs possess N-glycosidase activity that depurinates a 
highly conserved adenine residue within the specific 14 nucleotide region (also known as α-
sarcin/ricin loop) of the 28S ribosomal RNA (rRNA) subunit of 60S ribosome (Endo et al., 
1987; Endo & Tsurugi, 1987). There are three types of RIPs. Type 1 RIPs are monomeric N-
glycosidase enzymes of approximately 30 kDA molecular mass, and are frequently found in 
higher plants, e.g., pokeweed antiviral protein, trichosanthin, saporin, and luffin (Nielsen & 
Boston, 2001). In general, type I RIPs are not cytotoxic because they lack the means of 
entering the cell (B chain) to inactivate ribosomes (Lord et al., 1994).  
Type 2 RIPs are glycosylated heterodimers possessing an N-glycosidase enzyme (denoted A 
chain) linked through a disulfide bond to a galactose-binding lectin (denoted B-chain) that 
facilitates endocytosis (Lord et al., 1994; Stirpe & Battelli, 2006). Type 2 RIPs include potent 
toxins such as ricin, abrin (isolated from the seeds of rosary pea, Abrus precatorius), modeccin 
(from the fruits and roots of Adenia digitata), volkensin (from the roots of A. volkensii), and 
viscumins (from mistletoe, Viscum album; Lord et al., 1994). Some type 2 RIPs possess an 
aberrant or non-functional B-chain, hence are relatively nontoxic. These include nigrin b 
from the elderberry plant (Sambucus nigra), lectins from winter aconite (Eranthis hyemalis), 
and ebulin lectins from dwarf elder (S. ebulus). 
Type 3 RIPs are the least common class and resemble type I plant RIPs in catalytic activity 
and overall net charge (Nielsen & Boston, 2001). They are synthesized as inactive precursor 
molecules with a polypeptide insert in the active site region of the A chain domain 
(Chaudhry et al., 1994). 
3.1.2 Biochemistry of ricin 
Ricin is the most well-characterized member of the type 2 RIPs. It consists of two 
glycoprotein subunits, designated A chain (RTA) and B chain (RTB), of approximately 
equal molecular mass (~32 kDa) linked by a single disulfide bond (Fig. 3). The ricin toxin 
is stored in the matrix of the castor seed, together with a 120 kDa lectin called R. communis 
agglutinin I (RCA). RCA is composed of two ricin-like dimers. Although the nucleotide 
sequences of ricin and RCA are similar, these proteins are products of distinct genes 
(Kole, 2011); it has been suggested that the ricin gene evolved first and then duplicated to 
give rise to the RCA gene (Ready et al., 1984). Compared with ricin, RCA is virtually 
nontoxic (Olsnes et al., 1974) but is a powerful red blood cell agglutinin (Hegde & Podder, 
1992). 
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Fig. 3. Three-dimensional representation of ricin. The A chain (RTA) is depicted in red, the B 
chain (RTB) in blue, and the disulfide bond in yellow. (Image courtesy of Dr. Mark A. Olson, 
Integrated Toxicology Division, USAMRIID, Fort Detrick, MD). 
3.1.2.1 Primary structure of ricin/RCA 
The ricin protein’s coding region consists of a 24 amino acid N-terminal signal sequence 
preceding a 266 amino acid RTA. The RTB has 262 amino acids. A 12-amino acid linker joins 
the two chains. The nontranslated mRNA regions of ricin and RCA are identical (Roberts, et 
al., 1985; Lamb et al., 1985). The signal peptide preceding the RTA in both lectins and the linker 
peptide joining the RTA and RTB are also alike in size and amino acid sequence. Overall, the 
RCA and RTA chains are 93% homologous (18 amino acid variants) while the corresponding B 
chains differ in 41 amino acids, and are 84% homologous (Lamb et al., 1985). 
3.1.2.2 Ricin secondary structure 
The carboxyl-terminal end of the RTA folds into a domain that interacts between the two 
domains of the B chain (Montfort et al., 1987). A disulfide bond is formed at amino acid 259 of 
the RTA and amino acid 4 of the RTB (Robertus, 1988; 1991; Lord et al., 1994). Thirty percent of 
the RTA protein is helical (Fig. 4). The RTA folds into three somewhat arbitrary domains. The 
active site cleft of the RTA is located at the interface between all three domains. A 
conformational change occurs in the active site when the RTA is released from the RTB.  
 
Fig. 4. Ribbon representation of RTA. The RTA has three structural domains and exhibits a 
substantial amount of secondary structure. Color schemes: cyan = helix; magenta = strands; 
red = coil regions. (Image courtesy of Dr. Mark A. Olson, Integrated Toxicology Division,  
USAMRIID, Fort Detrick, MD).  
www.intechopen.com
 
Bioterrorism 
 
142 
3.2 Pathogenesis 
Ricin is a toxalbumin, a biological toxin whose mechanism of action is inhibition of protein 
synthesis in eukaryotic cells which results in cell death (CDC, 2006a). The dimeric A-B chain 
structure is crucial to cellular internalization and subsequent toxicity. Cell entry by ricin 
involves a series of steps, summarized as follows: 1) the RTB portion of the ricin molecule 
binds to cell surface glycolipids or glycoproteins possessing 1,4-linked galactose residues; 2) 
once bound to the cell surface, the toxin is internalized by endocytosis and routed to the 
cytosol. The presence of the B-chain facilitates transport of the A-chain into the cytosol; 3) 
toxin entry into early endosomes; 4) ricin vesicular transport from early endosomes to the 
trans-Golgi network; 5) retrograde vesicular transport through the Golgi network to reach 
the endoplasmic reticulum; 6) reduction of the disulfide bond connecting RTA and RTB; 7) 
partial unfolding of the RTA to render it translocationally competent to cross the 
endoplasmic reticulum (Endo et al., 1987; Olsnes & Koslov, 2001; Lord et al., 1994; 2003). 
Transport to the cytosol is the rate-limiting step during the decline in protein synthesis 
(Hudson and Neville, 1987). 
Once transported from the ER to the cytoplasm, the RTA can interact with the ribosome, 
which acts as a suicidal chaperone stimulating proper refolding and resumption of catalytic 
activity (Lord et al., 2003). Ricin has a Michaelis constant (KM) of 0.1 μmol/L for ribosomes 
and an enzymatic constant (Kcat) of 1,500/min. It depurinates a specific adenosine residue 
(A4324) near the 3’ end of 28S ribosomal RNA subunit in the 60S ribosome subunit 
(Robertus, 1991). This halts the binding of elongation factor-2, which then results in the 
inhibition of protein synthesis in eukaryotic cells (Endo et al., 1987). Catalytic studies 
showed that single ricin molecule in the cytosol can inactivate over 1500 ribosomes per 
minute and eventually kills the cell (Olsnes et al.,1975; Cawley and Houston, 1979).  
Ricin is more active against animal than plant or bacterial ribosomes (Cawley and Houston, 
1979). Ribosomes which lack the specific 28S subunit containing the GAGA tetranucleotide 
sequence are generally not susceptible to the toxin. 
3.3 Toxicity 
Ricin’s toxicity is dependent on a number of factors including route of exposure (inhalation, 
parenteral (injection), ingestion, dermal contact, or ocular contact), amount of toxin 
administered, and animal species.  
3.3.1 Route of administration 
Ricin is extremely toxic by inhalation, and least potent by the oral route. In mice, the 
approximate dose that is lethal to 50% of the exposed population (LD50) and time to death 
are, respectively, 3-5 μg/kg (Franz and Jaax, 1997) and 60 hours by inhalation (Kortepeter et 
al., 2001a), 20 mg/kg and 85 hours by ingestion (Franz and Jaax, 1997), 5 μg/kg and 90 
hours by intravenous injection (Franz and Jaax, 1997), and 24 μg/kg and 100 hours by 
subcutaneous injection (Franz and Jaax, 1997). Low oral toxicity is possibly due to poor toxin 
absorption and partial degradation in the gut. Higher toxicities by other routes may be 
related to accessibility of target-cell populations and the availability of toxin receptors 
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among cell types. Skin testing in mice showed no dermal toxicity, indicating poor 
absorption across the skin (Wannemacher & Anderson, 2005). 
3.3.2 Amount of toxin administered 
Ingestion and mastication of 3-6 castor beans is the estimated fatal dose in adults; the fatal 
dose in children is not known, but is likely less (CDC, 2006a). Most cases of castor bean 
ingestion do not result in poisoning, because: a) it is difficult for ricin to be released from 
ingested castor beans; b) ricin release requires mastication, and the degree of mastication is 
likely to be important in determining the extent of poisoning; and c) ricin is not as well 
absorbed through the gastrointestinal tract when compared to injection or inhalation (CDC, 
2006a).  
3.3.3 Animal species 
The lethality of ricin by different routes in several animal species was summarized by 
Millard & LeClaire (2007). By ingestion, the hens were the least sensitive to the toxin (LD50 = 
14 g/kg), and the horses were the most sensitive (LD50 = 0.1 g/kg). By injection, rabbits had 
an LD50 = 0.1 μg/kg (i.m.), and 0.5 μg/kg (i.v.), while guinea pigs had <1.1 μg/kg (i.v.) and 
0.8 μg/kg (i.m.) (Millard & LeClaire, 2007). 
3.4 Human toxicity 
Limited information is available regarding human toxicity. Based on animal experiments 
and accidental human exposures, the approximate LD50 and time to death for humans are, 
respectively, 3 μg/kg and 36-72 hours by inhalation, 30 μg/kg and 6-8 days by ingestion, 3 
μg/kg and 36-72 hours by intravenous injection, and 500 μg and 3-6 days by subcutaneous 
injection (based on Georgi Markov’s assassination) (Franz & Jaax, 1997; Maman & 
Yehezkelli, 2005; Mirarchi, 2010). 
The vulnerability of certain populations (e.g., children, pregnant women, the elderly, those 
with immunosuppression, or underlying respiratory or gastrointestinal tract disease) to the 
health effects of ricin exposure is unknown; however, persons with pre-existing tissue 
irritation or damage may sustain further injury upon ricin exposure (CDC, 2006a). 
3.5 Transmission 
Ricin may adhere to skin, nonetheless, person-to-person transmission through casual 
contact has not been reported. Ricin is transmitted by the airborne route through release of 
the toxin in the form of a powder, or a mist, or reaerosolization of ricin into the air from 
disturbed surfaces (CDC, 2006a). However, to be effective, the toxin would need to be 
dispersed in particles smaller than 5 microns (CDC, 2006a).  
4. Clinical symptoms, signs and pathology 
The clinical signs, symptoms, and pathological manifestations of ricin toxicity vary with the 
dose and route of exposure, as detailed below. For symptomatic patients, the clinical course 
presents with the rapid onset of nausea, vomiting, and abdominal pain. Gastrointestinal 
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bleeding, anuria, diarrhea, cramps, and vascular collapse can also occur (Challoner & 
McCarron, 1990). Most symptoms develop less than 6 hours after ingestion, although the lag 
time from ingestion of castor seeds to onset of symptoms has ranged from 15 minutes to 
almost 10 hours. Progression to death occurs within 36 to 72 hours of exposure, depending 
on the route of exposure and the dose received (CDC, 2008).  
4.1 Injection 
In humans, subcutaneous or intramuscular injection of high doses of ricin results in severe 
local lymphoid necrosis, gastrointestinal hemorrhage, liver necrosis, diffuse nephritis, and 
diffuse splenitis. Ricin injection leads to necrosis at the injection site, which may predispose 
one to secondary infection (Passeron et al., 2004). Crompton & Gall (1980) summarized the 
clinical signs and symptoms for the Bulgarian dissident Georgi Markov, whose well-
publicized assassination was attributed to intramuscular injection of ricin (~500 μg), as 
follows: there was an immediate local pain, followed by general weakness within about 5 
hours. This was followed by elevated temperature, nausea, and vomiting 15 to 24 hours 
later. Thirty-six hours after the incident, the patient was admitted to the hospital feeling 
very ill. He exhibited fever, tachycardia, normal blood pressure, swollen and sore lymph 
nodes in the affected groin, and and a 6-cm diameter area of induration and inflammation 
was observed at the injection site on his thigh. Over the next 48 hours, he became suddenly 
hypotensive and tachycardic; developed GI hemorrhage, hypovolemic shock, and renal 
failure. His white blood count was 26,300/mm3. Early on the third day after the attack, he 
became anuric and began vomiting blood. An electrocardiogram demonstrated complete 
atrioventricular conduction block. He died shortly thereafter; at the time of death, his white 
blood count was 33,200/mm3. The autopsy revealed pulmonary edema that was thought to 
have been secondary to Markov’s cardiac failure, hemorrhagic necrosis of the small bowel, 
and hemorrhages in lymph nodes near the injection site, myocardium, testicles, and 
pancreas (Crompton and Gall, 1980). 
A case of a 20-year-old male who allegedly committed suicide by injecting (s.c.) castor bean 
extract was reported to show severe weakness, nausea, dizziness, headache, chest, back, and 
abdominal pain 36 hours after the injection (Targosz et al., 2002). This patient subsequently 
developed a bleeding diathesis, liver failure, and renal failure. He succumbed to cardiac ar-
rest. Postmortem examination revealed hemorrhagic foci in the brain, myocardium, and the 
pleura (Targosz et al., 2002).  
A 36-year-old chemist who allegedly injected (i.m.) himself with an unknown amount of 
ricin prepared from homogenized castor seeds reportedly experienced headache and rigors 
10 hours after exposure. He then developed anorexia, nausea, sinus tachycardia, 
lymphadenopathy at the injection sites, and erythematous areas around the puncture 
wounds (Fine et al., 1992). 
In a clinical study involving cancer patients, intravenous administration of 40 low doses (18–
20 μg/m2 of estimated body surface area) of ricin was well tolerated (Fodstad et al., 1984). 
Flu-like symptoms with fatigue and muscular pain were common, and sometimes nausea 
and vomiting occurred. The symptoms began 4 to 6 hours after administration and lasted 
for 1 to 2 days. Phase I/II clinical trials of two experimental immunotoxins containing 
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deglycosylated RTA (RFT5.dgA and Ki-4.dgA) administered i.v. to Hodgkins’ lymphoma 
patients revealed maximum tolerated doses (MTDs) of 15 and 5 mg/m2 of estimated body 
surface area for RFT5.dgA and Ki-4.dgA, respectively (Schnell et al., 2003). 
4.2 Oral intoxication 
Ricin is less toxic by oral ingestion than by other routes (Rauber & Heard, 1985), probably 
due to poor absorption of the toxin and possibly partial enzymatic degradation in the di-
gestive tract. The effects of oral intoxication vary among individuals, are dose dependent, 
and have different signs and symptoms. Rauber & Heard (1985) reviewed 751 cases of castor 
bean ingestion and reported 14 fatalities (1.9% death rate). The number of beans ingested by 
patients who died greatly varied. For instance, of the two lethal cases of oral intoxication 
documented since 1930, one involved a 24-year-old man who ate 15 to 20 beans, and the 
other was a 15-year-old boy who had 10 to 12 beans. All of the described serious, or fatal 
cases of castor bean ingestion have the same general clinical history: rapid (less than a few 
hours) onset of nausea, vomiting, and abdominal pain followed by diarrhea, hemorrhage 
from the anus, anuria, cramps, dilation of the pupils, fever, thirst, sore throat, headache, 
vascular collapse, and shock. Death occurred on the third day or later. The most common 
autopsy findings in oral intoxication were multifocal ulcerations and hemorrhages of gastric 
and small-intestinal mucosa, which may be quite severe; lymphoid necrosis in the 
mesenteric lymph nodes, gut-associated lymphoid tissue (GALT), and spleen; Kupffer cell 
and liver necrosis; diffuse nephritis; and diffuse splenitis (Rauber & Heard, 1985; Bradberry 
et al., 2003). 
4.3 Inhalation 
There are no documented cases of aerosol exposure to ricin in humans. Lesions induced by 
oral and parenteral exposure are consistent with those from animal studies, suggesting that 
the same would hold true for aerosol exposures. An allergic syndrome has been reported in 
workers exposed to castor bean dust in or around castor oil-processing plants (Brugsch, 
1960). The clinical picture is characterized by the sudden onset of congestion of the nose and 
throat, itchiness of the eyes, urticaria, and tightness of the chest. In more severe cases, 
wheezing can last for several hours, and may lead to bronchial asthma. Affected individuals 
respond to symptomatic therapy and removal from the exposure source.  
5. Diagnosis 
Ricin poisoning can be diagnosed based on clinical and epidemiological information, e.g., 
ingestion of castor beans, or occurrence of multiple cases during a short period, suggesting a 
common-source etiology (Wortmann, 2004). Ricin intoxication should be suspected if 
clinicians are presented with a number of patients having acute lung injury. A covert 
dispersion of aerosolized ricin is expected to be diagnosed, post factum, only after clinical 
symptoms occur (Kortepeter et al., 2001b). One common problem encountered in patients 
treated with ricin immunotoxins is the VLS, in which fluids leak from blood vessels leading 
to hypoalbumina, weight gain and pulmonary edema (Ghetie & Vitetta, 1994a). In patients 
who may be targets of an assassination attempt, ricin injection should be considered if there 
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are signs of rapid onset of symptoms similar to VLS. Ricin ingestion should be suspected if 
patients with gastrointestinal hemorrhage and hypotension have eaten from the same food 
source.  
Because ricin is immunogenic, acute as well as convalescent sera should be obtained from 
patients 2 weeks after exposure for measurement of antibody response (Franz & Jaax, 1997). 
Immunoassay (for blood or other body fluids) or immunohistochemistry techniques (for 
direct analysis of tissues) may be useful for confirming ricin intoxication (Poli et al., 2007). 
However, identification of the toxin in body fluids or tissues is challenging because ricin is 
bound very quickly, and is also metabolized before excretion (Ramsden et al., 1989).  
Currently, two types of laboratory testing are available for suspected ricin exposures. For 
environmental cases (determined by the CDC for suspected exposures from the 
environment, or by the FDA for suspected exposures from food or medication), ricin can be 
detected qualitatively by time-resolved fluorescence immunoassay (TRFIA), and polymerase 
chain reaction (PCR) in specimens (e.g., filters, swabs, or wipes). For biologic samples, 
selected specimens can be assessed for urinary ricinine, a marker of ricin exposure, using 
HPLC-ESI-MS (CDC, 2006b).  
The differential diagnoses of aerosol exposure to ricin include staphylococcal enterotoxin B 
(SEB), community-acquired pneumonia, inhalational anthrax, Q fever, tularemia, plague, 
and exposure to pyrolysis by-products of organofluorine polymers, or other chemical 
warfare agents such as phosgene (Eitzen et al., 1998). For ingested ricin, differential 
diagnoses include enteric pathogens, enterotoxins, and other toxins, including caustic 
agents, mushroom species, hydrocarbons, and pharmaceuticals such as salicylates and 
colchicine. Several factors discriminate ricin intoxication from other agents, such as: 1) 
clinical progression despite antibiotics (as opposed to infectious agents); 2) lack of 
mediastinitis (as seen with pulmonary anthrax); 3) progressive decline in clinical status 
(patients exposed to SEB tend to stabilize), and a slower progression than patients exposed 
to phosgene (Eitzen et al., 1998; Kortepeter et al., 2001a; 2001b). 
5.1 Prognosis and cause of death 
Death from ricin exposure could occur within 36 to 72 hours (CDC, 2008). If death has not 
occurred within 3-5 days, the patient usually survives. A mortality rate of 1.9% (14 of 751 
patients) was reported after castor bean ingestion (Rauber & Heard, 1985). Even with little 
or no effective supportive care, the death rate in symptomatic patients has been 
approximately 6%. No information is available regarding human mortality rate after ricin 
inhalation.  
The exact cause of death from ricin poisoning possibly varies with route of exposure. Ricin 
ingestion results in ulceration and hemorrhage of the stomach and small intestine mucosa, 
necrosis of the mesenteric lymphatics, liver necrosis, nephritis, and splenitis (Poli et al., 2007). 
Injection of the toxin may lead to severe local lymphoid necrosis, gastrointestinal hemorrhage, 
liver necrosis, diffuse nephritis, and diffuse splenitis. Intravenous administration of ricin in 
rats resulted in diffuse damage to Kupffer cells within 4 hours, followed by endothelial cell 
damage, formation of thrombi in the liver vasculature, and finally, hepatocellular necrosis 
(Bingen et al., 1987; Derenzini et al., 1976). In mice, rats, and primates, high doses by inhalation 
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apparently produce lethal pulmonary damage, probably due to hypoxemia resulting from 
massive pulmonary edema and alveolar flooding (Poli et al., 2007). 
6. Medical management 
Currently, there is no FDA-approved therapeutic for ricin exposure. Countermeasures 
that have demonstrated capability to disrupt the ricin intoxication process include 
vaccines and antibody therapy. Both rely on the ability of antibody to prevent the 
binding of ricin to cell receptors. To ensure maximum protection, the vaccine must be 
given before exposure, and sufficient antibody must be produced. Similarly, 
administration of preformed antibodies affords maximum protection if antibody is 
present before exposure. 
Treatment is largely symptomatic and basically supportive to minimize the effects of the 
poisoning. Because ricin acts rapidly and irreversibly (directly on lung parenchyma after 
inhalation or is distributed rapidly to vital organs after parenteral exposure), postexposure 
therapy is more challenging than with slowly processed, peripherally acting agents that can 
be treated with antibiotics (Franz & Jaax, 1997).  
6.1 Vaccination and passive protection 
Inhalational exposure is best countered with active vaccination or prophylactic 
administration of aerosolized specific antibody (Franz and Jaax, 1997). However, there is 
currently no licensed vaccine available. Development of a ricin vaccine previously focused 
on either a deglycosylated ricin A chain or formalin-inactivated toxoid (Hewetson et al., 
1996). Both vaccines confer protection against aerosolized ricin. Nevertheless, ricin is not 
completely inactivated by formalin and may retain some of its enzymatic activity (albeit 
approximately 1,000-fold lower than native ricin). Deglycosylated ricin A chain may lead to 
local or systemic VLS.  
Recent research has focused on developing recombinant RTA subunit vaccines devoid of 
cytotoxicity and other potential deleterious activities. Several ricin vaccines candidates that 
are based on engineered RTA molecules have shown protection with different animal 
models, but demonstration of their human protection proved to be more challenging 
(Vitetta et al., 2005). USAMRIID has engineered a recombinant ricin vaccine 1-33/44-198 
(rRTA 1-33/44-198) (RVEc), with increased protein stability over the parent RTA subunit 
and devoid of enzymatic (N-glycosidase) activity (Olson et al., 2004), lacking vascular leak 
activity (Porter et al., 2011) described in RTA-based immunotoxins, and fully protected 
vaccinated animals against supralethal aerosol challenges (McHugh et al., 2004; Carra et al., 
2007). A cGLP pre-clinical toxicity study of RVEc in New Zealand white rabbits 
demonstrated that no treatment-related or toxicologically significant effects were observed 
with RVEc during this study (McClain et al., 2011). A phase I clinical study is ongoing at 
USAMRIID to evaluate the safety and immunogenicity of RVEc in humans (USAMRIID, 13 
April 2011; AP, 13 April 2011).  
A recombinant protein RTA vaccine, RiVax, has been developed based on mutations of both 
the enzymatic and a reported VLS-inducing site (Smallshaw et al., 2002). RiVax elicited 
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protective immunity in mice, and had sufficient pre-clinical safety data (Smallshaw et al., 
2005). Results from the initial Phase I human trial showed that RiVax appeared to be 
immunological and well tolerated in humans (Vitetta et al., 2006). However, while such 
results were encouraging, vaccine formulation and stability remain problematic. Hence, a 
lyophilized formulation that retained immunogenicity when stored at 4ºC was developed 
(Smallshaw & Vitetta, 2010; Marconescu et al., 2010).  
Passive protection with aerosolized anti-ricin immunoglobulin (IgG) has also been 
evaluated as prophylaxis before aerosol challenge. Administration of nebulized anti-ricin 
IgG effectively protected against lung lesions and lethality in mice when challenged with an 
aerosol exposure to ricin (Poli et al., 1996). Extrapolation of these data to clearance rates of 
IgG from the airways of rabbits suggests that anti-ricin–specific antibodies may provide 
protection for up to 2 to 3 days or longer. These findings imply that inhaling protective 
antibody from a portable nebulizer just before an attack might provide some protection in 
nonimmune individuals (Poli et al., 1996). However, the window of opportunity for 
treatment by intravenous administration or inhalation of specific antibody after exposure is 
probably minimal at best.  
Recent pre-clinical studies have shown the powerful protection afforded by neutralizing 
monoclonal antibodies (administered singly or in combination) against a lethal dose 
challenge of ricin, demonstrating proof of concept for passive immunotherapy for the 
treatment of ricin poisoning or for preexposure prophylaxis (Neal, 2010; 2011; Prigent, 
2011). 
6.2 Supportive and specific therapy 
Supportive medical care depends on the route of exposure and clinical manifestations. For 
oral intoxication, supportive therapy includes intravenous fluid, electrolyte replacement, 
monitoring of liver and renal functions, gastric emptying/lavage, syrup of ipecac, cathartics, 
and, activated charcoal (Ellenhorn, 1997; Franz & Jaax, 1997). Patients who have ingested 
beans and presented asymptomatic should remain under observation for 4-6 hours after 
ingestion. For inhalational intoxication, respiratory support is given as needed. Aerosol-
exposed patient may require the use of positive-pressure ventilator therapy, fluid and elec-
trolyte replacement, antiinflammatory agents, and analgesics (Kortepeter et al., 2001b). 
Dermal exposures require supportive treatment. Percutaneous exposures would necessitate 
judicious use of intravenous fluids and monitoring for symptoms associated with VLS, 
including hypotension, edema, and pulmonary edema (Poli et al., 2007). Supportive care 
includes correction of coagulopathies, respiratory support, and monitoring for liver and 
renal failure .  
Several research groups have engaged in the development of RTA active site inhibitors or 
RTB receptor antagonists as clinical antidotes against ricin poisoning, or as therapeutic 
adjuncts to vaccination. Small molecules that exhibited modest IC50 values (Bai et al., 2010; 
Wahome et al., 2010; Pang et al., 2011), including a compound that showed in vivo efficacy 
(Stechmann et al., 2010) have been described. An effective and essentially irreversible RTA 
inhibitor is thought to be practically useful as a pretreatment for military forces or civilian 
first-responders (Millard & LeClaire, 2007).  
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7. Medical therapy of ricin 
In addition to studies pertaining to the natural toxicity of the protein, ricin has also been 
used extensively in the design of therapeutic immunotoxins. In such, ricin, RTA, or a related 
toxin is chemically or genetically linked to a binding ligand such as an antibody or growth 
factor that recognizes cancer cells, then it may be taken up by the cancer cells and ultimately 
kill them (Frankel, 1988). Immunotoxins using RTA or blocked ricin, have been evaluated in 
phase I clinical trials for control of several cancers (Ghetie & Vitetta, 1994b; Lynch et al., 
1997; Schnell et al., 2003; Vitetta, 2006).  
8. Summary 
Ricin is a potent toxin derived from the seeds of the castor plant, R. communis. Because of its 
potency, stability, worldwide availability, and relative ease of production, ricin is 
considered a significant biological warfare or terrorism threat. Ricin was developed as an 
aerosol biological weapon by the U.S. and its allies during WWII, although it was never 
used in battle. As a biological or chemical weapon, ricin has not been considered as very 
powerful in comparison with other agents such as botulinum neurotoxin or anthrax. 
However, its effectiveness as a discrete weapon of terror-targeted assassinations, biocrimes, 
or small-scale operations does raise potential concern. Ricin’s popularity as well as its track 
record in actually being exploited by extremists groups and individuals highlight the need 
to be vigilant of its latent misuse. Clinical manifestations of ricin poisoning vary depending 
on the routes of exposure. Diagnosis is based upon both epidemiological and clinical 
parameters. Laboratory confirmation of clinical samples is possible by immunoassay but 
complicated by pharmacokinetic factors. Currently, there is no U.S. FDA-approved drug or 
vaccine against ricin poisoning. Treatment is purely supportive. Prophylaxis will be best 
accomplished by vaccination. Ricin vaccine candidates are currently in advanced 
development in laboratory and clinical trials. 
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